)
Katie Katie Sinaikin
Executive Director of Global Analytics & Insights
Revolution Medicines
Katie Sinaikin is Executive Director of Global Analytics & Insights at Revolution Medicines, where she leads market research, forecasting, competitive intelligence, and advanced analytics across a multi-asset oncology portfolio. With over 15 years of experience in the biopharma industry, she has shaped commercial and clinical strategy at leading companies including Gilead Sciences, Genentech, and Halozyme, with deep expertise in global launch strategy, portfolio valuation, and executive decision-making. Katie holds an MBA from the University of Chicago Booth School of Business and a BA in International Relations and Economics from Wellesley College.
Sessions
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}